


<PubmedArticle>
    <MedlineCitation Status="Publisher" Owner="NLM">
        <PMID Version="1">31200022</PMID>
        <DateRevised>
            <Year>2019</Year>
            <Month>06</Month>
            <Day>14</Day>
        </DateRevised>
        <Article PubModel="Print-Electronic">
            <Journal>
                <ISSN IssnType="Electronic">1872-7913</ISSN>
                <JournalIssue CitedMedium="Internet">
                    <PubDate>
                        <Year>2019</Year>
                        <Month>Jun</Month>
                        <Day>11</Day>
                    </PubDate>
                </JournalIssue>
                <Title>International journal of antimicrobial agents</Title>
                <ISOAbbreviation>Int. J. Antimicrob. Agents</ISOAbbreviation>
            </Journal>
            <ArticleTitle>Comparison of antimicrobial stewardship programs in acute care hospitals in four European countries: a cross-sectional survey.</ArticleTitle>
            <ELocationID EIdType="pii" ValidYN="Y">S0924-8579(19)30146-3</ELocationID>
            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ijantimicag.2019.06.005</ELocationID>
            <Abstract>
                <AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Antimicrobial stewardship programs (ASPs) are designed to improve antibiotic use. Recently, a survey was systematically developed to assess ASP prerequisites, objectives and improvement strategies in hospitals. We assessed the current state of ASP in acute care hospitals throughout Europe.</AbstractText>
                <AbstractText Label="METHODS" NlmCategory="METHODS">A survey containing 46 questions was disseminated to acute care hospitals: all Dutch (n=80) and Slovenian (n=29), 215 French (25%, random stratified sampling) and 61 Italian (49% of hospitals with an ID department, convenience sampling) acute care hospitals, for a European wide assessment.</AbstractText>
                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Response rates for the Netherlands (Nl), Slovenia (Slo), France (Fr) and Italy (It) were 80% (n= 64), 86% (n=25), 45% (n=97) and 66% (n=41). There was variation between countries in the prerequisites met, and the objectives and improvement strategies chosen. A formal ASP program was present mainly in the Netherlands (91%) and France (84%), as opposed to Slovenia (60%) and Italy (60%). Presence of a stewardship team ranged from 42% (Fr) up to 94% (Nl). Salary support for AMS-teams was provided in 68% (Fr), 51% (Nl), 33% (Slo) and 12% (It). The quantity of antibiotic use was monitored in the majority of the hospitals, ranging from 72% (Nl) to 100% (Slo and Fr). Participating countries varied substantially in the use of 'prospective monitoring and advice' as a strategy to improve stewardship objectives.</AbstractText>
                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">ASP prerequisites, objectives and improvement activities vary considerably across European countries, with room for improvement. Stimulating appropriate system prerequisites throughout Europe, for example by introducing staffing standards and financial support for ASPs, seems a first priority.</AbstractText>
                <CopyrightInformation>Copyright © 2019. Published by Elsevier B.V.</CopyrightInformation>
            </Abstract>
            <AuthorList CompleteYN="Y">
                <Author ValidYN="Y">
                    <LastName>Kallen</LastName>
                    <ForeName>M C</ForeName>
                    <Initials>MC</Initials>
                    <AffiliationInfo>
                        <Affiliation>Amsterdam UMC, University of Amsterdam, department of Internal Medicine, division of Infectious Diseases, Meibergdreef 9, Amsterdam, the Netherlands. Electronic address: m.c.kallen@amc.uva.nl.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Binda</LastName>
                    <ForeName>F</ForeName>
                    <Initials>F</Initials>
                    <AffiliationInfo>
                        <Affiliation>Université de Lorraine, APEMAC, Nancy, France; University of Milan, Department of Biomedical and Clinical Sciences « Luigi Sacco », Milan, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Ten Oever</LastName>
                    <ForeName>J</ForeName>
                    <Initials>J</Initials>
                    <AffiliationInfo>
                        <Affiliation>Radboud University Medical Center, department of Internal Medicine, Geert Grooteplein Zuid 10, Nijmegen, the Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Tebano</LastName>
                    <ForeName>G</ForeName>
                    <Initials>G</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases, Pitié-Salpêtrière Hospital, AP-PH, Paris, France; Sorbonne University, UPMC Univ Paris 06, INSERM, Institut Pierre Louis d'Epidémiologie et de Santé Publique (IPLESP UMRS 1136), Paris, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Pulcini</LastName>
                    <ForeName>C</ForeName>
                    <Initials>C</Initials>
                    <AffiliationInfo>
                        <Affiliation>Université de Lorraine, APEMAC, Nancy, France; Université de Lorraine, CHRU-Nancy, Infectious Diseases Department, Nancy, France.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Murri</LastName>
                    <ForeName>R</ForeName>
                    <Initials>R</Initials>
                    <AffiliationInfo>
                        <Affiliation>Institute of Infectious Diseases, Fondazione Policlinico Universitario A. Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Beovic</LastName>
                    <ForeName>B</ForeName>
                    <Initials>B</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases, University Medical Centre Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, Slovenia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Saje</LastName>
                    <ForeName>A</ForeName>
                    <Initials>A</Initials>
                    <AffiliationInfo>
                        <Affiliation>Department of Infectious Diseases, University Medical Centre Ljubljana, Slovenia; Faculty of Medicine, University of Ljubljana, Slovenia.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Prins</LastName>
                    <ForeName>J M</ForeName>
                    <Initials>JM</Initials>
                    <AffiliationInfo>
                        <Affiliation>Amsterdam UMC, University of Amsterdam, department of Internal Medicine, division of Infectious Diseases, Meibergdreef 9, Amsterdam, the Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Hulscher</LastName>
                    <ForeName>M E J L</ForeName>
                    <Initials>MEJL</Initials>
                    <AffiliationInfo>
                        <Affiliation>Radboud University Medical Center, Radboud Institute for Health Sciences, Scientific Center for Quality of Healthcare (IQ healthcare), Geert Grooteplein Zuid 10, Nijmegen, the Netherlands.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <LastName>Schouten</LastName>
                    <ForeName>J A</ForeName>
                    <Initials>JA</Initials>
                    <AffiliationInfo>
                        <Affiliation>Radboud University Medical Center, Radboud Institute for Health Sciences, Scientific Center for Quality of Healthcare (IQ healthcare), Geert Grooteplein Zuid 10, Nijmegen, the Netherlands; Radboud University Medical Center, department of Intensive Care Medicine, Geert Grooteplein Zuid 10, Nijmegen, the Netherlands. Electronic address: jeroen.schouten@radboudumc.nl.</Affiliation>
                    </AffiliationInfo>
                </Author>
                <Author ValidYN="Y">
                    <CollectiveName>ESGAP (ESCMID Study Group for Antimicrobial stewardshiP)</CollectiveName>
                </Author>
            </AuthorList>
            <Language>eng</Language>
            <PublicationTypeList>
                <PublicationType UI="D016428">Journal Article</PublicationType>
            </PublicationTypeList>
            <ArticleDate DateType="Electronic">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>11</Day>
            </ArticleDate>
        </Article>
        <MedlineJournalInfo>
            <Country>Netherlands</Country>
            <MedlineTA>Int J Antimicrob Agents</MedlineTA>
            <NlmUniqueID>9111860</NlmUniqueID>
            <ISSNLinking>0924-8579</ISSNLinking>
        </MedlineJournalInfo>
        <KeywordList Owner="NOTNLM">
            <Keyword MajorTopicYN="N">Antimicrobial stewardship</Keyword>
            <Keyword MajorTopicYN="N">Europe</Keyword>
            <Keyword MajorTopicYN="N">Improvement strategies</Keyword>
            <Keyword MajorTopicYN="N">Objectives</Keyword>
            <Keyword MajorTopicYN="N">Prerequisits</Keyword>
            <Keyword MajorTopicYN="N">Survey</Keyword>
        </KeywordList>
    </MedlineCitation>
    <PubmedData>
        <History>
            <PubMedPubDate PubStatus="received">
                <Year>2019</Year>
                <Month>03</Month>
                <Day>03</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="revised">
                <Year>2019</Year>
                <Month>05</Month>
                <Day>20</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="accepted">
                <Year>2019</Year>
                <Month>06</Month>
                <Day>02</Day>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="entrez">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="pubmed">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
            <PubMedPubDate PubStatus="medline">
                <Year>2019</Year>
                <Month>6</Month>
                <Day>15</Day>
                <Hour>6</Hour>
                <Minute>0</Minute>
            </PubMedPubDate>
        </History>
        <PublicationStatus>aheadofprint</PublicationStatus>
        <ArticleIdList>
            <ArticleId IdType="pubmed">31200022</ArticleId>
            <ArticleId IdType="pii">S0924-8579(19)30146-3</ArticleId>
            <ArticleId IdType="doi">10.1016/j.ijantimicag.2019.06.005</ArticleId>
        </ArticleIdList>
    </PubmedData>
</PubmedArticle>

